Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
US10227385B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 18, 2017 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Jan 18, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to building a chimeric polypeptide used for preventing or treating a Flaviviridae infection. The use of the inventive chimeric polypeptide for producing recombinant viral vectors such as a measles living viral vector is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.